Form 8-K - Current report:
SEC Accession No. 0001193125-26-323628
Filing Date
2026-07-29
Accepted
2026-07-29 16:03:42
Documents
11
Period of Report
2026-07-29
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d158934d8k.htm   iXBRL 8-K 25815
  Complete submission text file 0001193125-26-323628.txt   137444

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ino-20260729.xsd EX-101.SCH 3160
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20260729_lab.xml EX-101.LAB 17234
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20260729_pre.xml EX-101.PRE 10800
14 EXTRACTED XBRL INSTANCE DOCUMENT d158934d8k_htm.xml XML 3515
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 261217318
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)